...
首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >Differential effects of anti-metastatic mechanism of Tian-Xian liquid (TXL) and its bioactive fractions on human colorectal cancer models.
【24h】

Differential effects of anti-metastatic mechanism of Tian-Xian liquid (TXL) and its bioactive fractions on human colorectal cancer models.

机译:天仙液(TXL)及其生物活性成分的抗转移机制对人大肠癌模型的差异作用。

获取原文
获取原文并翻译 | 示例

摘要

AIM OF STUDY: This study aimed to elucidate and compare the anti-metastatic mechanism of Tian-Xian liquid (TXL) and its bioactive components namely butanol (BU), ethyl-acetate (EA) and aqueous (WA) fractions on human colorectal cancer in vitro (HT-29 cancer cells) and in vivo (nude mouse xenografts). MATERIALS AND METHODS: The anti-proliferative effects of TXL and its bioactive components in HT-29 cells were determined by MTT assay. Their modulations on the potential angiogenic and metastatic marker expressions on HT-29 cells and xenografts were investigated by real-time PCR and Western blot at transcriptional and translational levels, respectively. For the in vitro study, migration abilities of HT-29 cells were determined using wound healing assay. For the in vivo study, daily measurements of the tumor size and volume of the xenografts were also performed. RESULTS: TXL, BU, EA and WA effectively inhibited the proliferation of HT-29 cells in a dose- and time-dependent manner. The IC(50) value of TXL on HT-29 cells was obtained after incubation with 1% (v/v) TXL for 4h; whereas IC(50) values were obtained for the following bioactive components: BU at 1.25% (v/v); EA at 5% (v/v); and WA at 0.3125% (v/v). It was found that 1% (v/v) TXL significantly down-regulated MMP2 and MMP7 expression at both transcriptional and translational levels and it reduced MMP9 and VEGF protein expression in vitro. TXL decreased the metastatic ability of HT-29 cells as demonstrated by wound healing assay. TXL and its bioactive fractions caused no significant changes in the body weight indicating lack of toxicity to the xenografts. CONCLUSIONS: In summary, TXL multi-targeted to down-regulate the metastatic markers in both in vitro and in vivo models. However, the effects of its bioactive fractions were not obvious. This study profoundly elucidated the anti-proliferative mechanism of TXL, which is vital for the development of future anti-cancer regime in Chinese medicinal formulations.
机译:研究目的:本研究旨在阐明和比较天仙液体(TXL)及其生物活性成分(丁醇(BU),乙酸乙酯(EA)和水性(WA)级分)对人大肠癌的抗转移机制。体外(HT-29癌细胞)和体内(裸鼠异种移植物)。材料与方法:用MTT法测定了TXL及其生物活性成分在HT-29细胞中的抗增殖作用。通过实时PCR和蛋白质印迹分别在转录和翻译水平上研究了它们对HT-29细胞和异种移植物上潜在的血管生成和转移标志物表达的调节。对于体外研究,使用伤口愈合测定法测定HT-29细胞的迁移能力。对于体内研究,还每天测量异种移植物的肿瘤大小和体积。结果:TXL,BU,EA和WA有效抑制HT-29细胞的增殖,且呈剂量和时间依赖性。用1%(v / v)TXL孵育4h后,获得HT-29细胞上TXL的IC(50)值;而以下生物活性成分的IC(50)值则为:BU为1.25%(v / v); EA(5%(v / v));和WA为0.3125%(v / v)。发现1%(v / v)TXL在转录和翻译水平上均显着下调了MMP2和MMP7的表达,并在体外降低了MMP9和VEGF蛋白的表达。如伤口愈合试验所证实的,TXL降低了HT-29细胞的转移能力。 TXL及其生物活性成分不会引起体重的明显变化,表明对异种移植物没有毒性。结论:总的来说,在体外和体内模型中,TXL多靶点下调转移标志物。但是,其生物活性级分的作用并不明显。这项研究深刻地阐明了TXL的抗增殖机制,这对于未来中药制剂的抗癌机制的发展至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号